Abstract

BackgroundCancer genomes harbor hundreds to thousands of somatic nonsynonymous mutations. DNA damage and deficiency of DNA repair systems are two major forces to cause somatic mutations, marking cancer genomes with specific somatic mutation patterns. Recently, several pan-cancer genome studies revealed more than 20 mutation signatures across multiple cancer types. However, detailed cancer-type specific mutation signatures and their different features within (intra-) and between (inter-) cancer types remain largely unexplored.MethodsWe employed a matrix decomposition algorithm, namely Non-negative Matrix Factorization, to survey the somatic mutations in nine major human cancers, involving a total of ~2100 genomes.ResultsOur results revealed 3-5 independent mutational signatures in each cancer, implying that a range of 3-5 predominant mutational processes likely underlie each cancer genome. Both mutagen exposure (tobacco and sun) and changes in DNA repair systems (APOBEC family, POLE, and MLH1) were found as mutagenesis forces, each of which marks the genome with an evident mutational signature. We studied the features of several signatures and their combinatory patterns within and across cancers. On one hand, we found each signature may influence a cancer genome with different influential magnitudes even in the same cancer type and the signature-specific load reflects intra-cancer heterogeneity (e.g., the smoking-related signature in lung cancer smokers and never smokers). On the other hand, inter-cancer heterogeneity is characterized by combinatory patterns of mutational signatures, where no cancers share the same signature profile, even between two lung cancer subtypes (lung adenocarcinoma and squamous cell lung cancer).ConclusionsOur work provides a detailed overview of the mutational characteristics in each of nine major cancers and highlights that the mutational signature profile is representative of each cancer.

Highlights

  • Cancer genomes harbor hundreds to thousands of somatic nonsynonymous mutations

  • Each cancer has distinct and distinguishable mutational signatures pan-cancer analyses have been comprehensively performed in recent studies, cancer type specific mutation signatures were only explicitly examined in breast cancer

  • The non-CGI-signature: C → T in CG dinucleotides in non-CpG island (CGI) regions We found a signature characterized by C → T in the context of CG dinucleotides in seven of the nine cancers: Breast cancer (BRCA), colon and rectal cancers (CRC), endometrial carcinomas (EC), GBM, head and neck squamous cell carcinomas (HNSCC), lung adenocarcinomas (LUAD), and ovarian carcinomas (OvCa)

Read more

Summary

Introduction

Cancer genomes harbor hundreds to thousands of somatic nonsynonymous mutations. DNA damage and deficiency of DNA repair systems are two major forces to cause somatic mutations, marking cancer genomes with specific somatic mutation patterns. Several pan-cancer genome studies have been reported by The Cancer Genome Atlas (TCGA), aiming to study simultaneously thousands of cancer genomes across many cancer types [10,11,12,13,14] Through these studies, a total of 21 mutational signatures were extracted from 30 types of cancers, providing the landscape and a dictionary of mutational signatures in major cancers [10]. A total of 21 mutational signatures were extracted from 30 types of cancers, providing the landscape and a dictionary of mutational signatures in major cancers [10] These signatures confirmed previously recognized internal and external risk factors involving DNA damage, such as environmental DNAdamaging agents, tobacco carcinogens [15,16], radiation, and chemicals, and revealed novel mechanisms that mark cancer genomes with specific mutational patterns [2,17]. Heterogeneous mutational signatures and processes were highlighted as a prevalent phenomenon in cancer [13], further complicating the studies of cancer somatic mutations

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.